Back
Protagonist Therapeutics Vs. Merus NV Industry Stock Comparison
Buy
56
PTGX
Protagonist Therapeutics
Last Price:
33.37
Seasonality Move:
14.81%
Buy
74
MRUS
Merus NV
Last Price:
56.50
Seasonality Move:
6.15%
Buy
56
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $33.39. The Score for PTGX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
74
Merus NV (MRUS)
is a Buy
Is Merus NV a Buy, Sell or Hold?
- The current Merus NV [MRUS] share price is $56.55. The Score for MRUS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- MRUS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $33.39
The current trend is moderately bullish and PTGX is experiencing slight selling pressure.
MRUS Stock Price Chart
PTGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.48 | Buy |
Relative Strength Index (14 RSI): | 60.08 | Buy |
Chaikin Money Flow: | -119501 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.07 - 33.45) | Buy |
Bollinger Bands (100): | (26 - 31.02) | Buy |
MRUS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.72 | Buy |
Relative Strength Index (14 RSI): | 60.79 | Buy |
Chaikin Money Flow: | -65155 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.2 - 56.18) | Buy |
Bollinger Bands (100): | (39.85 - 50.89) | Buy |
PTGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.96 | Sell |
20-day SMA: | 31.55 | Buy |
50-day SMA: | 28.85 | Buy |
200-day SMA: | 23.59 | Buy |
8-day EMA: | 33.27 | Buy |
20-day EMA: | 31.77 | Buy |
50-day EMA: | 29.87 | Buy |
200-day EMA: | 25.42 | Buy |
MRUS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.05 | Buy |
20-day SMA: | 52.09 | Buy |
50-day SMA: | 47.26 | Buy |
200-day SMA: | 35.05 | Buy |
8-day EMA: | 55.4 | Buy |
20-day EMA: | 52.74 | Buy |
50-day EMA: | 48.89 | Buy |
200-day EMA: | 38.23 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $4.32 per share, and a decrease next year of $2.45 per share.
Merus NV Earnings Growth & MRUS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.24 per share, and a decrease next year of $0.33 per share.
Protagonist Therapeutics Technical Analysis
Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Merus NV Technical Analysis
Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |